Autopsy report · NCT01323582

Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis

“Original investigator left this institution, replacement investigator retired.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 1 month after it had already started.
• Ran for about 3 years 10 months before it stopped.
• 26 participants enrolled.
• Results were posted on the registry 2 years after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University of Florida

Sponsor type

University, hospital or other

Conditions

Gastroparesis

Interventions

Erythromycin; Azithromycin

Participants

26

Sites

1

Countries

United States

Trials that died the same way

• Use of Cast Iron Pots to Improve Maternal Anemia
  “Original investigator has left the institution.” (90% match in meaning)
• Intralesional Tetracycline Injection in the Treatment of Chalazia
  “Investigator left the institution” (87% match in meaning)
• Impact of Statins on Cytokine Expression in Pneumonia
  “Investigator left institution.” (85% match in meaning)
• Trial of Art Therapy During Cognitive Processing Therapy for PTSD
  “Investigator has retired.” (85% match in meaning)
• Pharmacogenomic Testing in Major Depressive Disorder
  “Investigator retired.” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.